Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Method for transitioning between Ziegler-Natta and metallocene catalysts in a bulk loop reactor for the production of polypropylene
Secure data exchange for processing requests
Multi-protocol data transfers
Touch sensing technology
Servo write assembly
Authenticated secret sharing
Leg stretching device
  Randomly Featured Patents
System for remote pass-phrase authentication
Trampoline with elastic frame attachment system
Simulated visual display system for a game device
Bifurcated gamma camera system
Clutch device having an elastic coupling for a flywheel
Image encoding apparatus and an image decoding apparatus
Hybrid tea rose plant named Devstar
Gas manifolds for use during epitaxial film formation
Projection type display apparatus
Aqueous isotropic personal liquid cleansing composition with triethanol amine soap, selected electrolyte and synthetic surfacant